Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

New AQUIOS CL Clinical Cytometer* For Routine Applications in Clinical Lab

Published: Tuesday, June 10, 2014
Last Updated: Wednesday, June 11, 2014
Bookmark and Share
The fully automated instrument delivers fast, efficient results.

Beckman Coulter Life Sciences is set to transform the use of flow cytometry in the routine clinical laboratory with its latest offering, the Aquios CL Clinical Flow Cytometer*. Fully automated, with a small footprint, the instrument is the first authentic ‘LOAD & GO’ cytometry system.

The Aquios CL is designed specifically to streamline workflow and reduce backlogs when handling routine applications, such as immunophenotyping. The Aquios CL delivers first results within 20 minutes, with subsequent results at a rate of 25 samples per hour for up to a full 96-well plate.  

As easy to learn and use as a haematology analyser, it can be operated with minimal training, freeing up resources for more complex assay analysis.  By removing manual processes, the high level of automation helps prevent sample processing errors.  Its cap-piercing technology reduces staff exposure to biohazardous samples.

This fully integrated system includes a 40-tube capacity autoloader able to handle a variety of tube sizes, with continuous, random loading and unloading.  There is a separate single-tube loader for STAT samples.  Sample preparation, reagent monitoring, barcode scanning, data analysis and LIS connectivity are all automated.  

* Pending submission and clearance by the United States Food and Drug Administration; not yet available for in vitro diagnostic use. The device has not yet been licensed in accordance with Canadian law. The performance specifications of this product have not been established.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Beckman Coulter Diagnostics Obtains CE Marks for DxN VERIS HCV Assay
Growing menu of assays allow for rapid turnaround of results with a more efficient workflow.
Thursday, June 11, 2015
FDA Clears Beckman's AQUIOS CL Flow Cytometer For Clinical Labs
The company's new, automated AQUIOS CL Flow Cytometer has received clearance from the U.S. Food and Drug Administration (FDA) for routine applications in the clinical laboratory.
Wednesday, May 06, 2015
Beckman Coulter Diagnostics and Seegene Supply Agreement
Supply agreement announced for multiplex reagents for VERIS molecular diagnostics system.
Monday, November 17, 2014
Beckman Coulter Obtains CE Mark for VERIS MDx System
Beckman Coulter Diagnostics has obtained CE Mark for the VERIS MDx System* and VERIS human Cytomegalovirus (CMV) assay*.
Monday, May 12, 2014
Beckman To Acquire Cytometer Developer Xitogen
Acquisition will broaden product offering, providing an Asian operations centre.
Wednesday, April 23, 2014
New Beckman Coulter Assay Receives FDA Clearance and CE Mark
Assay is first to standardize to World Health Organization’s 5th International Standard for chorionic gonadotropin.
Friday, January 17, 2014
Scientific News
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos